Prolonged Activated Partial Thromboplastin Time after Successful Resuscitation from Cardiac Arrest is Associated with Unfavorable Neurologic Outcome.
Adult
Aged
Blood Coagulation
Blood Coagulation Disorders
/ blood
Brain
/ physiopathology
Female
Heart Arrest
/ blood
Humans
Male
Middle Aged
Neurologic Examination
Partial Thromboplastin Time
Patient Admission
Predictive Value of Tests
Recovery of Function
Registries
Resuscitation
/ adverse effects
Return of Spontaneous Circulation
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
Journal
Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
pubmed:
14
11
2020
medline:
16
11
2021
entrez:
13
11
2020
Statut:
ppublish
Résumé
Coagulation abnormalities after successful resuscitation from cardiac arrest may be associated with unfavorable neurologic outcome. We investigated a potential association of activated partial thromboplastin time (aPTT) with neurologic outcome in adult cardiac arrest survivors. Therefore, we included all adults ≥18 years of age who suffered a nontraumatic cardiac arrest and had achieved return of spontaneous circulation between January 2013 and December 2018. Patients receiving anticoagulants or thrombolytic therapy and those subjected to extracorporeal membrane oxygenation support were excluded. Routine blood sampling was performed on admission as soon as a vascular access was available. The primary outcome was 30-day neurologic function, assessed by the Cerebral Performance Category scale (3-5 = unfavorable neurologic function). Multivariable regression was used to assess associations between normal (≤41 seconds) and prolonged (>41 seconds) aPTT on admission (exposure) and the primary outcome. Results are given as odds ratio (OR) with 95% confidence intervals (95% CIs). Out of 1,591 cardiac arrest patients treated between 2013 and 2018, 360 patients (32% female; median age: 60 years [interquartile range: 48-70]) were eligible for analysis. A total of 263 patients (73%) had unfavorable neurologic function at day 30. aPTT prolongation >41 seconds was associated with a 190% increase in crude OR of unfavorable neurologic function (crude OR: 2.89; 95% CI: 1.78-4.68,
Identifiants
pubmed: 33186992
doi: 10.1055/s-0040-1719029
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
477-483Subventions
Organisme : SFB54-04
ID : Austrian Science Fund FWF
Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
None declared.